Mechanistic investigations into the encapsulation and release of small molecules and proteins from a supramolecular nucleoside gel in vitro and in vivo.

Biocompatibility Biomaterials Drug delivery Gel erosion Mechanism Proteins Self-assembled materials Small molecules

Journal

Journal of controlled release : official journal of the Controlled Release Society
ISSN: 1873-4995
Titre abrégé: J Control Release
Pays: Netherlands
ID NLM: 8607908

Informations de publication

Date de publication:
10 01 2020
Historique:
received: 20 09 2018
revised: 13 08 2019
accepted: 02 10 2019
pubmed: 5 11 2019
medline: 22 6 2021
entrez: 4 11 2019
Statut: ppublish

Résumé

Supramolecular gels have recently emerged as promising biomaterials for the delivery of a wide range of bioactive molecules, from small hydrophobic drugs to large biomolecules such as proteins. Although it has been demonstrated that each encapsulated molecule has a different release profile from the hydrogel, so far diffusion and steric impediment have been identified as the only mechanisms for the release of molecules from supramolecular gels. Erosion of a supramolecular gel has not yet been reported to contribute to the release profiles of encapsulated molecules. Here, we use a novel nucleoside-based supramolecular gel as a drug delivery system for proteins with different properties and a hydrophobic dye and describe for the first time how these materials interact, encapsulate and eventually release bioactive molecules through an erosion-based process. Through fluorescence microscopy and spectroscopy as well as small angle X-ray scattering, we show that the encapsulated molecules directly interact with the hydrogel fibres - rather than being physically entrapped in the gel network. The ability of these materials to protect proteins against enzymatic degradation is also demonstrated here for the first time. In addition, the released proteins were proven to be functional in vitro. Real-time fluorescence microscopy together with macroscopic release studies confirm that erosion is the key release mechanism. In vivo, the gel completely degrades after two weeks and no signs of inflammation are detected, demonstrating its in vivo safety. By establishing the contribution of erosion as a key driving force behind the release of bioactive molecules from supramolecular gels, this work provides mechanistic insight into the way molecules with different properties are encapsulated and released from a nucleoside-based supramolecular gel and sets the basis for the design of more tailored supramolecular gels for drug delivery applications.

Identifiants

pubmed: 31678096
pii: S0168-3659(19)30568-1
doi: 10.1016/j.jconrel.2019.10.011
pii:
doi:

Substances chimiques

Biocompatible Materials 0
Hydrogels 0
Nucleosides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

118-129

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/L013827/1
Pays : United Kingdom

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Maria Galini Faidra Angelerou (MG)

School of Pharmacy, University of Nottingham, UK.

Robert Markus (R)

SLIM Imaging Unit, Faculty of Medicine and Health Sciences, School of Life Sciences, University of Nottingham, Nottingham NG7 2RD, UK.

Vasiliki Paraskevopoulou (V)

School of Pharmacy, University of Nottingham, UK.

Rugerro Foralosso (R)

School of Pharmacy, University of Nottingham, UK.

Philip Clarke (P)

School of Medicine, University of Nottingham, Queen's Medical Centre, UK.

Clara V Alvarez (CV)

School of Medicine, University of Santiago de Compostela, Spain.

Miguel Chenlo (M)

School of Medicine, University of Santiago de Compostela, Spain.

Litty Johnson (L)

School of Pharmacy, University of Nottingham, UK.

Catrin Rutland (C)

School of Veterinary Medicine and Science, Faculty of Medicine, University of Nottingham, Sutton Bonington, UK.

Stephanie Allen (S)

School of Pharmacy, University of Nottingham, UK.

Christopher Brasnett (C)

HH Wills Physics Laboratory, Tyndall Avenue, University of Bristol, BS8 1TL, UK.

Annela Seddon (A)

HH Wills Physics Laboratory, Tyndall Avenue, University of Bristol, BS8 1TL, UK; Bristol Centre for Functional Nanomaterials, HH Wills Physics Laboratory, Tyndall Avenue, University of Bristol, BS8 1TL, UK.

Mischa Zelzer (M)

School of Pharmacy, University of Nottingham, UK. Electronic address: mischa.zelzer@nottingham.ac.uk.

Maria Marlow (M)

School of Pharmacy, University of Nottingham, UK. Electronic address: maria.marlow@nottingham.ac.uk.

Articles similaires

Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Animals Osteogenesis Osteoporosis Mesenchymal Stem Cells Humans

Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.

Prashant Kesharwani, Kratika Halwai, Saurav Kumar Jha et al.
1.00
Chitosan Humans Folic Acid Nanoparticles Drug Carriers

Classifications MeSH